JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
PRSU
2901
Pursuit Attractions and Hospitality Inc
PRSU
$1.43B
| $7.51M | ﹤0.01% |
176,724
+63,915
| +57% | +$2.64M |
2013 Q2
46 quarters
|
|
|
THR
2902
DELISTED
Thermon Group Holdings
THR
| $7.51M | ﹤0.01% |
261,111
-13,116
| -5% | -$386K |
2017 Q4
28 quarters
|
|
|
VPU
2903
Vanguard Utilities ETF
VPU
$7.72B
| $7.51M | ﹤0.01% |
45,945
+8,206
| +22% | +$1.4M |
2018 Q1
27 quarters
|
|
2904
Concentrix
CNXC
$1.52B
| $7.49M | ﹤0.01% |
173,203
+17,073
| +11% | +$759K |
2020 Q4
16 quarters
|
|
2905
Upwork
UPWK
$1.01B
| $7.49M | ﹤0.01% |
457,801
+118,956
| +35% | +$1.71M |
2018 Q4
24 quarters
|
|
2906
PUT
Roku
ROKU
$22.6B
| $7.47M | ﹤0.01% |
100,500
+100,000
| +20,000% | +$7.58M |
2021 Q1
15 quarters
|
|
2907
Capital Group International Focus Equity ETF
CGXU
$6.84B
| $7.47M | ﹤0.01% |
302,759
+24,027
| +9% | +$625K |
2023 Q4
4 quarters
|
|
2908
Fidelity MSCI Financials Index ETF
FNCL
$2.23B
| $7.47M | ﹤0.01% |
108,739
+12,007
| +12% | +$825K |
2017 Q1
31 quarters
|
|
2909
Virtu Financial
VIRT
$5.19B
| $7.47M | ﹤0.01% |
209,272
-148,793
| -42% | -$5.12M |
2020 Q1
19 quarters
|
|
2910
Westamerica Bancorp
WABC
$1.38B
| $7.47M | ﹤0.01% |
142,330
+60,871
| +75% | +$3.26M |
2013 Q2
46 quarters
|
|
2911
First Mid Bancshares
FMBH
$1.33B
| $7.44M | ﹤0.01% |
202,039
+68,907
| +52% | +$2.74M |
2017 Q4
28 quarters
|
|
2912
Tompkins Financial
TMP
$1.42B
| $7.44M | ﹤0.01% |
109,668
+47,382
| +76% | +$3.28M |
2013 Q2
46 quarters
|
|
2913
Universal Corp
UVV
$1.05B
| $7.43M | ﹤0.01% |
135,563
+60,580
| +81% | +$3.25M |
2013 Q2
46 quarters
|
|
|
HTLF
2914
DELISTED
Heartland Financial USA, Inc.
HTLF
| $7.43M | ﹤0.01% |
121,244
-56,038
| -32% | -$3.51M |
2013 Q2
46 quarters
|
|
2915
NCR Atleos
NATL
$3.36B
| $7.42M | ﹤0.01% |
218,614
+113,619
| +108% | +$3.44M |
2023 Q4
4 quarters
|
|
2916
CALL
Inspire Medical Systems
INSP
$2.02B
| $7.42M | ﹤0.01% |
+40,000
| New | +$7.76M |
2024 Q4
0 quarters
|
|
2917
CALL
Enterprise Products Partners
EPD
$78.1B
| $7.41M | ﹤0.01% |
236,300
-41,600
| -15% | -$1.28M |
2021 Q2
14 quarters
|
|
2918
AngioDynamics
ANGO
$635M
| $7.4M | ﹤0.01% |
807,483
+254,322
| +46% | +$1.87M |
2016 Q1
35 quarters
|
|
2919
IES Holdings
IESC
$13.5B
| $7.39M | ﹤0.01% |
73,518
-9,446
| -11% | -$1.14M |
2017 Q4
28 quarters
|
|
2920
CALL
Albertsons Companies
ACI
$5.7B
| $7.38M | ﹤0.01% |
375,800
+374,900
| +41,656% | +$7.11M |
2024 Q3
1 quarter
|
|
2921
Tenaya Therapeutics
TNYA
$126M
| $7.37M | ﹤0.01% |
5,155,596
+5,130,774
| +20,670% | +$11.5M |
2021 Q3
13 quarters
|
|
2922
State Street SPDR Portfolio High Yield Bond ETF
SPHY
$11.7B
| $7.37M | ﹤0.01% |
313,992
+89,681
| +40% | +$2.13M |
2023 Q1
7 quarters
|
|
|
KREF
2923
KKR Real Estate Finance Trust
KREF
$361M
| $7.36M | ﹤0.01% |
728,875
+175,603
| +32% | +$2.01M |
2017 Q4
28 quarters
|
|
2924
CALL
Zimmer Biomet
ZBH
$16.8B
| $7.35M | ﹤0.01% |
69,600
| – | – |
2023 Q3
5 quarters
|
|
2925
Progyny
PGNY
$1.94B
| $7.34M | ﹤0.01% |
425,682
+57,606
| +16% | +$894K |
2019 Q4
20 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.